Table 7.
The top 15 cited original research related to the GM/CI.
| Rank | Title | First author | Year | Journals | IF | Partition | TC |
|---|---|---|---|---|---|---|---|
| 1 | Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors | Routy, B. | 2018 | Science | 47.728 | Q1 | 2104 |
| 2 | Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients | Gopalakrishnan, V. | 2018 | Science | 47.728 | Q1 | 1816 |
| 3 | Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy | Sivan, A. | 2015 | Science | 47.728 | Q1 | 1730 |
| 4 | Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota | Vetizou, M. | 2015 | Science | 47.728 | Q1 | 1596 |
| 5 | Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment | Iida, N. | 2013 | Science | 47.728 | Q1 | 1116 |
| 6 | Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab | Chaput, N. | 2017 | Ann. Oncol. | 32.976 | Q1 | 514 |
| 7 | Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis | Dubin, K. | 2016 | Nat. Commun. | 14.919 | Q1 | 496 |
| 8 | A defined commensal consortium elicits CD8 T cells and anti-cancer immunity | Tanoue, T. | 2019 | Nature | 49.962 | Q1 | 396 |
| 9 | Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes | Riquelme, E. | 2019 | Cell | 41.584 | Q1 | 377 |
| 10 | Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer | Derosa, L. | 2018 | Ann. Oncol. | 32.976 | Q1 | 376 |
| 11 | Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects | Daillere, R. | 2016 | Immunity | 31.745 | Q1 | 347 |
| 12 | Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis | Wang, Y. | 2018 | Nat. Med. | 53.44 | Q1 | 276 |
| 13 | Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients | Frankel, AE. | 2017 | Neoplasia | 5.715 | Q2 | 261 |
| 14 | Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients | Baruch, EN. | 2021 | Science | 47.728 | Q1 | 226 |
| 15 | Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy | Mager, LF | 2020 | Science | 47.728 | Q1 | 212 |